Health and Healthcare

Health and Healthcare Articles

More people die every year from poor diet than from smoking, yet medical schools spend little time educating future doctors about nutrition.
On a day that the Dow Jones industrials and S&P 500 just hit all-time highs, many companies are not exactly feeling the same love. Bluebird Bio is one such company.
Wright Medical Group shares exploded on Monday after it was announced that the firm would be acquired by Stryker.
Redhill Bio shares jumped early on Monday after the firm announced that the FDA approved Talicia for the treatment of Helicobacter pylori infection in adults.
Biogen and Alkermes have announced that the FDA approved Vumerity for the treatment of relapsing forms of multiple sclerosis.
When Amgen released its third-quarter financial results after the markets closed on Tuesday, the firm said that it had $3.66 in earnings per share (EPS) and $5.7 billion in revenue. That compared...
Amgen is set to report its most recent quarterly results after the closing bell on Tuesday. Wall Street expectations are muted.
Shares of Merck and Pfizer both got boosts after they reported their most recent quarterly results before the opening bell Tuesday.
Merck and Pfizer are set to report their most recent quarterly results before the opening bell tomorrow. Pfizer is one of the most shorted of all Dow stocks.
Melinta shares dropped on Friday even though the firm announced that the FDA has approved Baxdela (delafloxacin) for the treatment of adult patients with community-acquired bacterial pneumonia.
The October 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
The October 15 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
Eli Lilly shares retreated after it released mixed third-quarter financial results before the markets opened on Wednesday.
Eton Pharma shares jumped on Tuesday after the firm announced that the FDA has approved Biorphen for treatment of hypotension.
Biogen released its third-quarter financial results and Alzheimer’s trial news before the markets opened on Tuesday.
AI Portfolio

Discover Our Top AI Stocks

Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.

You can follow him investing $500,000 of his own money on our top AI stocks for free.